Zuckerman Investment Group Acquires 123,255 Shares in Harmony Biosciences

Got story updates? Submit your updates here. ›

Zuckerman Investment Group LLC acquired a new position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) during the 3rd quarter, purchasing 123,255 shares valued at approximately $3,397,000. The move comes as several other hedge funds and institutional investors have also recently bought and sold shares of the company.

Why it matters

Harmony Biosciences is a commercial-stage biopharmaceutical company focused on developing and delivering therapies for people with rare neurological and endocrine diseases. The acquisition of a sizable stake by Zuckerman Investment Group suggests confidence in the company's growth potential and product pipeline.

The details

According to a regulatory filing, Zuckerman Investment Group LLC acquired the new position in Harmony Biosciences during the third quarter of 2022. The 123,255 shares purchased represent a significant investment, valued at around $3.4 million. In addition to Zuckerman, a number of other hedge funds and institutional investors have also recently bought and sold shares of Harmony Biosciences, including Thrivent Financial for Lutherans, Nebula Research & Development LLC, Amalgamated Bank, and Profund Advisors LLC.

• Zuckerman Investment Group LLC acquired the new position in Harmony Biosciences during the 3rd quarter of 2022.